Literature DB >> 32014614

Atypical immunohistochemical patterns can complement the histopathological diagnosis of oral premalignant lesions.

Mikihito Ikeda1, Kaori Shima1, Tomoyuki Kondo1, Ichiro Semba2.   

Abstract

BACKGROUND: The histopathological diagnosis of oral premalignant lesions (OPLs) such as oral epithelial dysplasia (ED) and carcinoma in situ (CIS), as well as epithelial hyperplasia (EHP), is important for the early detection and precise treatment of oral squamous cell carcinoma. However, the standardization of detection and treatment by histological criteria alone remains challenging owing to the complicated and varied histology. We evaluated practically useful immunohistochemical (IHC) markers that might complement the histopathological diagnosis of OPLs.
METHODS: We re-evaluated the histopathological diagnoses and IHC patterns of Ki-67, TP53, CK13, and CK17 in 200 cases of OPLs and performed multiple logistic regression analyses for their predictive accuracy.
RESULTS: We identified and compared atypical IHC patterns in OPLs and in the normal epithelium. Ki-67 expression showed specific patterns in categorized OPLs as EHP, low-grade dysplasia (LED), high-grade dysplasia (HED), and CIS. Multiple logistic regression analyses in the quadrant categories revealed that EHP and CIS had high predictive accuracies of 90.1% and 96.2%, respectively, and in binary categories, combined EHP and LED versus combined HED and CIS showed predictive accuracies of 92.1% and 89.9%, respectively. Binominal logistic regression analysis between each quadrant category revealed satisfactory predictive accuracy of EHP vs. LED, LED vs. HED, and HED vs. CIS (75.2%, 78.9%, and 87.9%, respectively), and Ki-67 showed the highest adjusted odds ratio, followed by TP53.
CONCLUSION: The proposed atypical IHC patterns might serve as useful markers to supplement the morphological diagnosis of OPLs, and established IHC methods for Ki-67 and TP53 might provide stable results.
Copyright © 2020 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Ki-67 antigen; Oral precancerous condition; TP53 protein

Mesh:

Year:  2020        PMID: 32014614     DOI: 10.1016/j.job.2020.01.003

Source DB:  PubMed          Journal:  J Oral Biosci        ISSN: 1349-0079


  3 in total

1.  Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.

Authors:  Sirima Sanguansin; Theerachai Kosanwat; Rachai Juengsomjit; Sopee Poomsawat
Journal:  Int J Dent       Date:  2021-11-22

2.  Differential immunohistochemical expression of DEC1, CK‑1ε, and CD44 in oral atypical squamous epithelium and carcinoma in situ.

Authors:  Fuyuki Sato; Ujjal K Bhawal; Shoko Osaki; Nao Sugiyama; Kosuke Oikawa; Yasuteru Muragaki
Journal:  Mol Med Rep       Date:  2022-03-10       Impact factor: 2.952

3.  Novel cytological model for the identification of early oral cancer diagnostic markers: The carcinoma sequence model.

Authors:  Masami Kawaharada; Manabu Yamazaki; Satoshi Maruyama; Tatsuya AbÉ; Nyein Nyein Chan; Taiichi Kitano; Tadaharu Kobayashi; Takeyasu Maeda; Jun-Ichi Tanuma
Journal:  Oncol Lett       Date:  2022-01-11       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.